|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.810 USD | -5.17% |
|
+11.66% | -0.11% |
| 03-05 | Truist Initiates Vanda Pharmaceuticals at Buy With $18 Price Target | MT |
| 03-05 | Vanda Pharmaceuticals Insider Sold Shares Worth $1,276,971, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 521M | - | - | - | ||
| 42.98B | |||||
| 39.24B | |||||
| 30.07B | - | ||||
| 21.88B | - | ||||
| 18.25B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition